CIAM
CUE icon

Caitong International Asset Management’s Cue Biopharma CUE Stock Holding History

Caitong International Asset Management’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32 Buy
+1
New +$23 ﹤0.01% 2427

Other funds holding CUE

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM

Caitong International Asset Management's CUE Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Cue Biopharma (CUE) in Q2 2026: 1 share worth $32. The stake represents ﹤0.01% of the portfolio and ranks #2427 among its holdings.

49 funds tracked by Wall St. Rank hold CUE as of Q2 2026.

  • Caitong International Asset Management held 1 share of Cue Biopharma worth $32 as of Q2 2026.
  • Cue Biopharma was a new Caitong International Asset Management position in Q2 2026.
  • Cue Biopharma made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2427 holding.
  • 49 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.